Tekla Life Sciences Investors Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Stronger technical forecast for Tekla Life Sciences Investors stock price after Friday trading.
(Updated on May 03, 2024)
The Tekla Life Sciences Investors stock price gained 0.82% on the last trading day (Friday, 3rd May 2024), rising from $13.48 to $13.59. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 1.15% from a day low at $13.56 to a day high of $13.72. The price has risen in 7 of the last 10 days and is up by 6.17% over the past 2 weeks. Volume fell on the last day by -12 thousand shares and in total, 54 thousand shares were bought and sold for approximately $739.85 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Given the current short-term trend, the stock is expected to fall -7.62% during the next 3 months and, with a 90% probability hold a price between $11.61 and $12.55 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
HQL Signals & Forecast
The Tekla Life Sciences Investors stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $13.21 and $13.24. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 6.25%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Support, Risk & Stop-loss for Tekla Life Sciences Investors stock
Tekla Life Sciences Investors finds support from accumulated volume at $13.48 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.157 between high and low, or 1.15%. For the last week the stock has had daily average volatility of 1.58%
Our recommended stop-loss: $13.04 (-4.06%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 12 days ago.)
Trading Expectations (HQL) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect Tekla Life Sciences Investors to open at $13.62, and during the day (based on 14 day Average True Range), to move between $13.40 and $13.78, which gives a possible trading interval of +/-$0.186 (+/-1.37%) up or down from last closing price. If Tekla Life Sciences Investors takes out the full calculated possible swing range there will be an estimated 2.74% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $13.48 (0.81%) than the resistance at $13.82 (1.69%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Tekla Life Sciences Investors stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.
Current score: 3.476 Buy Candidate Upgraded
Predicted Opening Price for Tekla Life Sciences Investors of Monday, May 6, 2024
| Fair opening price May 6, 2024 | Current price |
|---|---|
| $13.62 ( 0.237%) | $13.59 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for HQL
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 13.78 | 1.39 % | |
| R2 | 13.72 | 0.95 % | ||
| R1 | 13.68 | 0.677 % | ||
| Current price: | 13.59 | |||
| Support | S1 | 13.56 | -0.203 % | |
| S2 | 13.53 | -0.475 % | ||
| S3 | 13.47 | -0.92 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 14.11 | 3.83 % | |
| R2 | 13.90 | 2.28 % | ||
| R1 | 13.82 | 1.69 % | ||
| Current price | 13.59 | |||
| Support | S1 | 13.48 | -0.81% | |
| S2 | 13.10 | -3.61% | ||
| S3 | 12.79 | -5.89% |
HQL Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Feb 21, 2024 | Feb 21, 2024 | Mar 28, 2024 | $0.390 | 2.86% |
| 2 | Nov 09, 2023 | Nov 21, 2023 | Jan 10, 2024 | $0.300 | 2.09% |
| 3 | Aug 15, 2023 | Aug 24, 2023 | Sep 29, 2023 | $0.320 | 2.57% |
| 4 | May 15, 2023 | May 24, 2023 | Jun 30, 2023 | $0.320 | 2.36% |
| 5 | Feb 15, 2023 | Feb 24, 2023 | Dec 31, 2018 | $0.330 | 2.18% |
FAQ
Click here for our free guide on how to buy Tekla Life Sciences Investors Stock.
